AIDS research and human retroviruses 2017 11 22() doi 10.1089/AID.2017.0253
HBV and HCV coinfection with HIV has become a major concern for the survival of HIV patients. HBV, HCV coinfection with HIV is less reported in risk population especially in India. Persons presenting for HIV testing at a large testing center in Chennai, India were screened for HIV, HBV, and HCV infections with serologic testing. Prevalence of these infections was compared between heterosexual and injection drugs using (IDU) risk groups. Of 1612 persons presenting for testing, 502 (31%) were HIV infected, 131 (8%) were HBV infected and 618 (38%) were HCV infected. HIV/HBV, HIV/HCV and HBV/HCV co-infections were seen in 2%, 16% and 2% respectively. HIV/HBV/HCV triple infection was seen in 2% of participants. Except HIV infection, HBV, HCV and other coinfections were significantly associated with IDUs (p <0.05). The prevalence of HIV infection was higher among those reporting heterosexual risk than IDU risk and the prevalence of HBV infection was low among the HIV infected. As might be expected, the overall prevalence of HIV, HBV and HCV co-infections were high among IDU risk participants.